Immuneering SG&A Expense (Quarterly) Trends

Immuneering Corp (IMRX)

1.64 +0.08 (+5.13%) USD | NASDAQ | May 03, 16:00

1.64 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	4.385M
September 30, 2023	3.869M
June 30, 2023	4.045M
March 31, 2023	4.461M
December 31, 2022	4.107M
September 30, 2022	3.836M
June 30, 2022	3.704M
March 31, 2022	3.952M

Date	Value
December 31, 2021	3.149M
September 30, 2021	2.599M
June 30, 2021	1.34M
March 31, 2021	1.184M
December 31, 2020	1.138M
September 30, 2020	0.699M
June 30, 2020	0.629M
March 31, 2020	0.644M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.629M

Minimum

Jun 2020

4.461M

Maximum

Mar 2023

2.734M

Average

3.426M

Median

SG&A Expense (Quarterly) Benchmarks